Resapp Health (RAP.AX) Stock Price
Resapp Health Price
Resapp Health (RAP.AX) Stock | ISIN AU000000RAP5. The current Resapp Health stock price is 0.04 AUD (2026). Market capitalization is 32.65 M AUD. Resapp Health operates in the Health sector.
Revenue has compounded at 16.1% per year over the past 17 years to 2.51 M AUD. Resapp Health's net margin stands at -282.1%, up from -7,509.7% several years earlier.
Resapp Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Resapp Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Resapp Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Resapp Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Resapp Health Price |
|---|
Resapp Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Resapp Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M AUD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M AUD) |
| NET INCOME (M AUD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 2 | 16 | 37 | 85 |
| – | – | – | – | – | 700 | 131.25 | 129.73 |
| – | – | – | – | - | - | - | - |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -6 | -5 | -8 | -6 | -7 | 0 | 0 | 0 |
| -40 | -16.67 | 60 | -25 | 16.67 | – | – | – |
| 659.04 | 685.19 | 707.79 | 778.3 | 859.22 | 859.22 | 859.22 | 859.22 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Resapp Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Resapp Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Resapp Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Resapp Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Resapp Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Resapp Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Resapp Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Resapp Health business model & stock analysis
Resapp Health SWOT Analysis
Strengths
Resapp Health Ltd possesses several strengths that contribute to its success in the healthcare industry. Firstly, the company's proprietary technology offers a non-invasive and convenient solution for diagnosing respiratory conditions. This provides a competitive advantage over traditional diagnostic methods.
Furthermore, Resapp Health Ltd has a strong intellectual property portfolio, protecting their innovative technology and ensuring differentiation from competitors. This allows them to capitalize on their unique offering and maintain a strong market position.
Weaknesses
Despite its strengths, Resapp Health Ltd also faces certain weaknesses that need to be addressed for sustainable growth. One such weakness is the company's heavy reliance on partnerships and collaborations for commercialization and market penetration. This dependence exposes the company to potential risks, such as partnership failures or delays in product development.
Additionally, Resapp Health Ltd has limited financial resources compared to larger competitors in the industry. This could constrain their ability to invest in research and development, marketing efforts, and expanding their operations, potentially limiting their growth potential.
Opportunities
Resapp Health Ltd operates in a rapidly growing digital health market, which presents various opportunities for future success. The increasing adoption of telehealth services and remote patient monitoring creates a favorable market environment for the company's respiratory diagnostic solutions. By positioning themselves as a leader in this space, Resapp Health Ltd can capitalize on the growing demand for convenient and accurate healthcare solutions.
Furthermore, expanding their product offerings to cover other respiratory conditions and diseases opens up new avenues for revenue growth for Resapp Health Ltd. This diversification can help mitigate market risks and increase their market share.
Threats
Resapp Health Ltd faces several potential threats within the healthcare industry. One significant threat is the high level of competition from both established players and emerging start-ups with similar respiratory diagnostic solutions. These competitors may have greater financial resources, larger customer bases, or stronger brand recognition, posing a challenge to Resapp Health Ltd's market position.
Another threat is the ever-changing regulatory landscape in the healthcare industry. Compliance with evolving regulations and obtaining necessary approvals can be resource-intensive and time-consuming for Resapp Health Ltd. Failure to comply with regulatory requirements could result in delays or restrictions in product commercialization.
Resapp Health Eulerpool Fair Value
Resapp Health historical P/E ratio, EBIT multiple, and P/S ratio
Resapp Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Resapp Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Resapp Health shareholder structure
| % | Name |
|---|---|
4.1724% | |
2.29857% | |
1.89451% | |
1.19004% | |
1.04746% | |
1.01575% | |
0.93073% | |
0.91361% | |
0.82281% | |
0.68698% |
Resapp Health Executives and Management Board
David Mandel
Director · since 2009
Dr. Roger Aston
Non-Executive Chairman of the Board
Mr. Mike Connell
Vice President - Commercial
Mr. Brian Leedman
Executive Director · since 2016
Ms. Nicki Farley
Company Secretary · since 2012
Resapp Health Supply Chain
Frequently asked questions about Resapp Health
Resapp Health Ltd is a medical technology company that specializes in the development of innovative respiratory diagnostic and management solutions. Their business model revolves around designing and commercializing smartphone-based applications, algorithms, and software solutions for the diagnosis and management of respiratory conditions. By utilizing the power of artificial intelligence and machine learning, Resapp Health Ltd aims to provide accurate, accessible, and cost-effective respiratory healthcare to patients worldwide. With a focus on improving respiratory disease outcomes, their technologies have the potential to revolutionize the way respiratory conditions are diagnosed and managed, ultimately leading to better patient outcomes and reduced healthcare costs.
Resapp Health stock
Resapp Health Peer Group
Resapp Health FIGI
All fundamentals and in-depth analysis of Resapp Health
Our stock analysis for Resapp Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Resapp Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.